Upon evaluating the instrumental variables (IVs) included in our study, we discerned that elevated levels of IL-6 significantly augment the risk of EMs onset (OR = 1.351, 95% CI = 1.015–1.797). The gene discussed is IL6; the disease is eosinophilia-myalgia syndrome.